Literature DB >> 12693956

Defining the molecular components of calcium transport regulation in a reconstituted membrane system.

Laxma G Reddy1, Razvan L Cornea, Deborah L Winters, Edward McKenna, David D Thomas.   

Abstract

Using a chemically defined reconstitution system, we performed a systematic study of key factors in the regulation of the Ca-ATPase by phospholamban (PLB). We varied both the lipid/protein and PLB/Ca-ATPase ratios, determined the effects of PLB phosphorylation, and compared the regulatory effects of several PLB mutants, as a function of Ca concentration. The reconstitution system allowed us to determine accurately not only the PLB effects on K(Ca) (Ca concentration at half-maximal activity) of the Ca-ATPase, but also the effects on V(max) (maximal activity). Wild-type PLB (WT-PLB) and two gain-of-function mutants, N27A-PLB and I40A-PLB, showed not only the previously reported increase in K(Ca), but also an increase in V(max). Specifically, V(max) increases linearly with the intramembrane PLB concentration, and is approximately doubled when the sample composition approaches that of cardiac SR. Upon phosphorylation of PLB at Ser-16, the K(Ca) effects were almost completely reversed for WT- and N27A-PLB but were only partially reversed for I40A-PLB. Phosphorylation induced a V(max) increase for WT-PLB, and a V(max) decrease for N27A- and I40A-PLB. We conclude that PLB and PLB phosphorylation affect V(max) as well as K(Ca), and that the magnitude of both effects is sensitive to the PLB concentration in the membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12693956     DOI: 10.1021/bi026995a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure.

Authors:  Elizabeth L Lockamy; Razvan L Cornea; Christine B Karim; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2011-04-12       Impact factor: 3.575

2.  Probing ground and excited states of phospholamban in model and native lipid membranes by magic angle spinning NMR spectroscopy.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Gianluigi Veglia
Journal:  Biochim Biophys Acta       Date:  2011-08-03

3.  Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.

Authors:  David Hermanson; Sadiya N Addo; Anna A Bajer; Jonathan S Marchant; Sonia Goutam Kumar Das; Balasubramanian Srinivasan; Fawaz Al-Mousa; Francesco Michelangeli; David D Thomas; Tucker W Lebien; Chengguo Xing
Journal:  Mol Pharmacol       Date:  2009-06-26       Impact factor: 4.436

4.  Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A.

Authors:  Kim N Ha; Larry R Masterson; Zhanjia Hou; Raffaello Verardi; Naomi Walsh; Gianluigi Veglia; Seth L Robia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region.

Authors:  Erik K Larsen; Daniel K Weber; Songlin Wang; Tata Gopinath; Daniel J Blackwell; Michael P Dalton; Seth L Robia; Jiali Gao; Gianluigi Veglia
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-08-07       Impact factor: 3.747

6.  Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.

Authors:  Brandy L Akin; Zhenhui Chen; Larry R Jones
Journal:  J Biol Chem       Date:  2010-07-11       Impact factor: 5.157

7.  Protein-protein interactions in calcium transport regulation probed by saturation transfer electron paramagnetic resonance.

Authors:  Zachary M James; Jesse E McCaffrey; Kurt D Torgersen; Christine B Karim; David D Thomas
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

8.  Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions.

Authors:  Vitaly V Vostrikov; Kailey J Soller; Kim N Ha; T Gopinath; Gianluigi Veglia
Journal:  Biochim Biophys Acta       Date:  2014-09-22

9.  Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation.

Authors:  Xiaoqiong Dong; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2014-05-09       Impact factor: 3.575

10.  Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone.

Authors:  Christine B Karim; Tara L Kirby; Zhiwen Zhang; Yuri Nesmelov; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.